pipobroman has been researched along with Enlarged Spleen in 6 studies
Pipobroman: An antineoplastic agent that acts by alkylation.
pipobroman : An N-acylpiperazine that is piperazine in which each of the nitrogens has been acylated by a 3-bromopropionoyl group. An anti-cancer drug.
Excerpt | Relevance | Reference |
---|---|---|
"An analysis of the risk of progression towards leukemia, carcinoma and myelofibrosis was performed in 93 patients treated by 32P alone (PVSG protocols) since 1970-1979, 395 patients over the age of 65 years treated by 32P with or without maintenance therapy using hydroxyurea (French protocol) since 1980-1994, and 202 patients under the age of 65 treated by either hydroxyurea or pipobroman since 1980." | 6.18 | Risk of leukaemia, carcinoma, and myelofibrosis in 32P- or chemotherapy-treated patients with polycythaemia vera: a prospective analysis of 682 cases. The "French Cooperative Group for the Study of Polycythaemias". ( Dresch, C; Echard, M; Goguel, A; Grange, MJ; Lejeune, F; Najean, Y; Rain, JD, 1996) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (50.00) | 18.7374 |
1990's | 2 (33.33) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Rain, JD | 2 |
Boivin, P | 2 |
Najean, Y | 1 |
Dresch, C | 1 |
Goguel, A | 1 |
Lejeune, F | 1 |
Echard, M | 1 |
Grange, MJ | 1 |
Jamshidi, K | 1 |
Ansari, A | 1 |
Windschitl, HE | 1 |
Swaim, WR | 1 |
Bilski-Pasquier, G | 1 |
Blanc, CM | 1 |
Bousser, J | 1 |
Vallée, G | 1 |
Dormont, J | 1 |
Soulier, JP | 1 |
2 reviews available for pipobroman and Enlarged Spleen
Article | Year |
---|---|
[Polycythemia vera].
Topics: Aged; Diagnosis, Differential; Erythrocyte Count; Female; Hematocrit; Humans; Hydroxyurea; Male; Mid | 2002 |
Risk of leukaemia, carcinoma, and myelofibrosis in 32P- or chemotherapy-treated patients with polycythaemia vera: a prospective analysis of 682 cases. The "French Cooperative Group for the Study of Polycythaemias".
Topics: Actuarial Analysis; Acute Disease; Carcinoma; Cause of Death; Disease Progression; Follow-Up Studies | 1996 |
2 trials available for pipobroman and Enlarged Spleen
Article | Year |
---|---|
Indications, procedure and results for the treatment of polycythaemia vera by bleeding, pipobroman and hydroxyurea.
Topics: Acute Disease; Bloodletting; Combined Modality Therapy; Humans; Hydroxyurea; Leukemia; Phosphorus Ra | 1993 |
Risk of leukaemia, carcinoma, and myelofibrosis in 32P- or chemotherapy-treated patients with polycythaemia vera: a prospective analysis of 682 cases. The "French Cooperative Group for the Study of Polycythaemias".
Topics: Actuarial Analysis; Acute Disease; Carcinoma; Cause of Death; Disease Progression; Follow-Up Studies | 1996 |
3 other studies available for pipobroman and Enlarged Spleen
Article | Year |
---|---|
Primary thrombocythemia.
Topics: Adult; Aged; Blood Coagulation Tests; Bone Marrow Examination; Busulfan; Follow-Up Studies; Gastroin | 1973 |
[Treatment of Vaquez's polycythemia with 1-4, bis-3-bromopropionyl-piperazine. Study of 36 cases].
Topics: Aged; Antineoplastic Agents; Bromine; Erythrocyte Count; Female; Humans; Leukemia, Myeloid; Leukopen | 1968 |
[Present treatment of the Vaquez's disease].
Topics: Aged; Anemia; Anticoagulants; Antineoplastic Agents; Blood Donors; Blood Volume; Bloodletting; Busul | 1969 |